The global market for anticoccidial drugs is estimated to reach $2.85 billion by 2020 at a CAGR of 3.67%. The livestock industry has seen steady growth over the past two decades and the antibiotic market has been growing along with it.
Coccidiosis, a parasitic infection of the intestinal tract of animals is caused by coccidian protozoa. The disease feasts from one animal to another by any contact with infected faeces or consumption of infected tissue. It infects a wide variety of animals, such as cattle, poultry species, pigs and sheep. It can be responsible for devastating mislay in meat production. To overcome this problem, anticoccidial drugs play an important role in the prevention and treatment of coccidiosis.
The ban on consumption of antibiotics as a source of animal feed and the upsurge in incidences of antibiotic microbes has seen a reduced growth in the antibiotic market, nevertheless the rising incidence of coccidiosis over the preceding 50 years and its control on the overall cost to benefit ratio for the meat industry has furthered the anticoccidials drug market.
Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/327688
Growing demand for meat proteins are increasing usage of anticoccidial drugs and are the driving force for global anticoccidial drugs market. Besides, less stringent regulations and increased expenditure on companion animals are also assistant in growth of global anticoccidial drugs market. Further, the trend of owning companion animals is causative to the growing usage of anticoccidials in developing regions.
The global anticoccidial drugs market is classified based on various types of animals and by type of drugs. The animal segment is further sub-categorised into poultry, swine, fish, cattle and companion animals. The companion animal further includes dogs and cats. The drug segment includes antibiotic anticoccidials, Ionophore anticoccidials and chemical derivative anticoccidials. Furthermore, based on geography the market is segmented into various regions namely North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa.
North America dominates the global anticoccidial drugs market owing to preventive usage of anticoccidials in animal feed. Its countries combined contribute around 24% of the worldwide market for anticoccidial drugs. The U.S. holds the largest market share for anticoccidial drugs followed by Mexico and Canada in North America. Germany, France, Spain and U.K holds major share of the European anticoccidial drugs market
Key Player Analysis:
The industry is and will remain to face diverse challenges related to microbial resistance build-up and government regulations in US and Europe, consequently the major players will be focusing on the not as much of regulated markets in the South America and Asia Pacific regions. These being the regions estimated to grow the most during the forecasted period.
Some of the few key players operating in the market are Bayer Health care, Zoetis, Elanco, Merial, Merck Animal Healthcare, Virbac, Ceva Santé Animale, Boehringer Ingelheim Animal Health, Novartis Animal Healthcare and Smartvet Inc.
Major Points From The Table Of Contents:
Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
Market Leaders’ Analysis
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019